Electroacustimulation for the prevention of PONV-A multimodal approach
Not Applicable
Completed
- Conditions
- R11Nausea and vomiting
- Registration Number
- DRKS00005664
- Lead Sponsor
- niversitätsklinikum Essen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 650
Inclusion Criteria
Operation in the gynecology or ENT department in high risk patients for development of PONV
Exclusion Criteria
Nickel allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of postoperative nausea and vomiting within 6h after end of operation by questionnaire
- Secondary Outcome Measures
Name Time Method 1. Incidence of postoperative nause and vomiting within 24h after operation<br>2. usage of rescue medication within 24h
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie electroacustimulation's antiemetic effects in postoperative nausea and vomiting?
How does electroacustimulation compare to standard antiemetic regimens like ondansetron in preventing PONV?
Are there specific biomarkers that predict response to electroacustimulation in R11-related nausea and vomiting?
What adverse events are associated with electroacustimulation as a PONV prevention strategy?
What combination therapies with electroacustimulation show promise for multimodal PONV management?